This grant from the NIH offers additional funding to the Data Coordinating Center (DCC) for Type 1 Diabetes Acute Pancreatitis Consortium (T1DAPC) to conduct longitudinal Magnetic Resonance Imaging (MRI) and biomarker studies. The original 5-year observational study focuses on new onset diabetes during acute pancreatitis episodes, specifically type 1 diabetes (T1D), exploring incidence, evolution, etiology, and pathophysiology. The DCC manages data, biosamples, and funding distribution to clinical centers. Eligible for application by the current DCC’s Program Director/Principal Investigator, this opportunity aims to enhance understanding of diabetes development post-acute pancreatitis.
Opportunity ID: 332636
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DK-21-501 |
| Funding Opportunity Title: | Limited Competition: Revision to the Longitudinal Monitoring of Pancreas Architecture in the Type 1 Diabetes in Acute Pancreatitis Consortium – Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | 1 |
| Assistance Listings: | 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 05, 2021 |
| Last Updated Date: | Apr 05, 2021 |
| Original Closing Date for Applications: | Aug 17, 2021 |
| Current Closing Date for Applications: | Aug 17, 2021 |
| Archive Date: | Sep 22, 2021 |
| Estimated Total Program Funding: | $1,500,000 |
| Award Ceiling: | $1,500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See FOA for full eligibility details. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) invites one application from the Program Director/Principal Investigator (PD/PI) of the current Data Coordinating Center (DCC) for Type 1 Diabetes Acute Pancreatitis Consortium (T1DAPC). This 5-year longitudinal observational clinical study was originally funded in September 2020 and is currently in its planning phase. It will conduct a prospective longitudinal observational study of the occurrence of new onset diabetes during an acute pancreatitis (AP) episode or subsequently, with an emphasis on type 1 diabetes (T1D). The study is designed to gain insight into the incidence, clinical evolution, etiology, type and pathophysiology of the T1D and other forms of diabetes after AP. The DCC is involved in coordination and study design, including data and biosample acquisition and management and is responsible for distribution of funding to the clinical centers for participant costs. This supplement provides funding for the T1DAPC DCC to support longitudinal Magnetic Resonance Imaging (MRI) and other types of biomarker studies of enrolled participants. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-21-501.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00266353 | Jul 17, 2021 | Aug 17, 2021 | View |
Package 1
Mandatory forms
332636 RR_SF424_2_0-2.0.pdf
332636 PHS398_CoverPageSupplement_5_0-5.0.pdf
332636 RR_OtherProjectInfo_1_4-1.4.pdf
332636 PerformanceSite_2_0-2.0.pdf
332636 RR_KeyPersonExpanded_2_0-2.0.pdf
332636 PHS398_ResearchPlan_4_0-4.0.pdf
332636 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
332636 RR_Budget_1_4-1.4.pdf
332636 RR_SubawardBudget30_1_4-1.4.pdf
332636 PHS398_ModularBudget_1_2-1.2.pdf
332636 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
